Compumedics Limited (ASX:CMP)
Australia · Delayed Price · Currency is AUD 0.2600
0.00 (0.00%)
Oct 7, 2026, 3:16 PM AEST
Compumedics Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 61.88 | 61.88 | 51.04 | 50.26 | 42.92 | 38.61 |
Revenue Growth | 5.79% | 21.23% | 1.55% | 17.10% | 11.18% | 8.02% |
Gross Profit Gross Profit Growth | 32.64 | 32.64 | 28.13 | 26.61 | 22.11 | 20.17 |
Operating Income Operating Income Growth | 3.44 | 3.44 | 0.9 | -0.27 | -3.02 | 0.99 |
Net Income Net Income Growth | 0.25 | 0.25 | -1.27 | -0.34 | -6.12 | 1.36 |
Earnings Per Share EPS Growth | 0.00 | 0.00 | -0.01 | -0.00 | -0.03 | 0.01 |
EPS Growth | 261.96% | - | - | - | - | 35.97% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Inter-Segment Elimination Inter-Segment Elimination Growth | -17.17 | -17.17 | -11.68 | -7.66 | -6.43 | -9.45 |
Europe & The Middle East Europe & The Middle East Growth | 17 | 17 | 13.03 | 10.59 | 12.77 | 13.89 |
Australia and Asia Pacific Australia and Asia Pacific Growth | 42.53 | 42.53 | 31.3 | 35.84 | 23.56 | 20.64 |
Americas Americas Growth | 17.9 | 17.9 | 18.18 | 10.95 | 12.51 | 12.67 |
Total Total Growth | 60.25 | 60.25 | 50.83 | 49.72 | 42.41 | 37.76 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 6.15 | 6.15 | 2.69 | 1.89 | 3.8 | 7.29 |
Total Debt Total Debt Growth | 14.7 | 14.7 | 13.88 | 8.58 | 9.47 | 6.55 |
Net Cash (Debt) Net Cash Growth | -8.56 | -8.56 | -11.19 | -6.69 | -5.67 | 0.75 |
Net Cash Growth | - | - | - | - | - | -21.47% |
Net Cash Per Share Net Cash Per Share Growth | -0.04 | -0.04 | -0.06 | -0.04 | -0.03 | 0.00 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 6.64 | 6.64 | 0.45 | 2 | 0.05 | 3.29 |
Capital Expenditures CapEx Growth | -0.18 | -0.18 | -0.21 | -0.31 | -0.92 | -0.62 |
Free Cash Flow Free Cash Flow Growth | 6.46 | 6.46 | 0.23 | 1.69 | -0.88 | 2.67 |
Free Cash Flow Growth | 49.17% | 2670.82% | -86.20% | - | - | 130.06% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 52.74% | 52.74% | 55.11% | 52.94% | 51.50% | 52.25% |
Operating Margin | 5.56% | 5.56% | 1.75% | -0.53% | -7.03% | 2.56% |
Pretax Margin | 2.74% | 2.74% | -0.81% | 0.95% | -15.65% | 4.40% |
Profit Margin | 0.41% | 0.41% | -2.48% | -0.67% | -14.26% | 3.52% |
FCF Margin | 10.43% | 10.43% | 0.46% | 3.36% | -2.04% | 6.92% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 7, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 260.26 | 201.34 | - | - | - | 20.24 |
Forward PE | 12.38 | 8.10 | 11.59 | 11.41 | 11.41 | 11.41 |
P/FCF Ratio | 8.04 | 7.89 | 210.17 | 35.16 | - | 10.28 |
PS Ratio | 0.84 | 0.82 | 0.96 | 1.18 | 0.74 | 0.71 |